The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study

Bülent Berker; Salih Taşkin; Korhan Kahraman; Elif Aylin Taşkin; Cem Atabekoğlu; Murat Sönmezer

doi:10.1016/j.fertnstert.2010.12.033

The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study

Fertil Steril. 2011 Jun 30;95(8):2499-502. doi: 10.1016/j.fertnstert.2010.12.033. Epub 2011 Jan 17.

Authors

Bülent Berker¹, Salih Taşkin, Korhan Kahraman, Elif Aylin Taşkin, Cem Atabekoğlu, Murat Sönmezer

Affiliation

¹ Department of Obstetrics and Gynecology, Medical School of Ankara University, Ankara, Turkey.

PMID: 21244861
DOI: 10.1016/j.fertnstert.2010.12.033

Abstract

Low-molecular-weight heparin did not provide any beneficial effect on pregnancy outcomes in patients with two or more implantation failures. Further trials are needed to confirm a trend in favor of low-molecular-weight heparin in the subgroup with women with three or more implantation failures.

Publication types

Randomized Controlled Trial

MeSH terms

Adult
Embryo Implantation / drug effects*
Embryo Transfer*
Enoxaparin / therapeutic use*
Female
Humans
Infertility / therapy*
Pregnancy
Pregnancy Rate
Pregnancy, Multiple
Prospective Studies
Reproductive Techniques, Assisted*
Sperm Injections, Intracytoplasmic*
Treatment Failure
Turkey
Young Adult

Substances

Enoxaparin